Califf's Priorities Feature Short- And Long-Term Goals Despite Potentially Brief Tenure
This article was originally published in The Rose Sheet
Executive Summary
Newly confirmed FDA Commissioner Robert Califf should not assume he will be leaving once a new president arrives, a Republican-appointed predecessor says.
You may also be interested in...
Califf Returns To US FDA Helm As Familiar Consumer Health Regulation Problems Continue
Announcement of Senate confirmation of Robert Califf as commissioner came shortly after FDA announced recalls of products labeled as supplements but spiked with ED drugs. Like those and others recently identified as adulterated, supplements with undisclosed drugs were being found during Califf’s first stint in 2016 and 2017.
EWG To FDA Commish: Sunscreen SPFs Require ‘Urgent’ Investigation
The Environmental Working Group renews its call for a cap on SPF values at 50+, asking FDA to investigate whether anti-inflammatory ingredients added to sunscreen formulations are boosting SPFs without providing meaningful protection against UV damage. The NGO also recommends changes to the agency’s SPF testing requirements to improve the accuracy of labeled SPF claims.
EWG Lobbyists Keep Eye On Prize: The Personal Care Products Safety Act
The Environmental Working Group is working with industry leaders to urge the Senate HELP Committee to take up the PCPSA "as soon as possible," the NGO says. EWG's Scott Faber noted in an interview that "there are very few issues pending before the Senate that are bipartisan and that have the support of both industry and public health organizations," which could work in the bill's favor in a challenging Congress.